Helicobacter pylori and Clostridium difficile in cystic fibrosis patients.

Dig Dis Sci 2006 Dec 1;51(12):2274-9. Epub 2006 Nov 1.

Helicobacter Research Institute, Rabin Medical Center, Beilinson Campus, Petah Tikva, 49100, Israel.

We describe the prevalence of H. pylori and toxigenic Clostridium difficile (CD) infection and its relationship with gastrointestinal symptoms and pancreatic sufficiency (PS) or insufficiency (PI) in cystic fibrosis (CF) patients. Stool specimens from 30 consecutive patients with CF, aged 1-44, and from 30 healthy similarly aged subjects were tested for the H. pylori antigen by specific monoclonal antibodies and for CD toxins by Tox A/B assay and Tox A assay. CF patients were assessed clinically and tested for specific H. pylori serum antibodies and for mutations. In CF patients, the prevalence of H. pylori antigen was 16.6% (5/30), compared to 30% (9/30) in controls. Of the 26 CF patients with PI, only 2 (7.6%) were infected by H. pylori, compared with 3 of the 4 (75%) patients with PS (P=0.001). H. pylori infection was diagnosed in 3 of 5 (60%) CF patients carrying mild mutations, compared to 1 of 25 (4%) CF patients carrying severe mutations (P=0.01). Fourteen of 30 (46.6%) stool specimens from CF patients tested positive in the ToxA/B assay, and 3 of 14 tested positive for ToxA. No significant differences in antibiotic use, severity of lung disease, PI, chronic abdominal pain, or genotype were found between the two groups. None of the controls was positive for CD toxins. Prevalence of H. pylori infection in CF patients was lower than in similarly aged non-CF controls. CF patients with PI or a history of distal intestinal obstruction syndrome and those carrying mutations associated with a severe phenotype were protected against H. pylori infection. Almost half of the CF patients were asymptomatic carriers of CD producing mostly toxin B. More studies are needed to confirm our results in a larger group of CF patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-006-9271-5DOI Listing
December 2006
4 Reads

Publication Analysis

Top Keywords

patients
14
prevalence pylori
12
pylori infection
12
fibrosis patients
8
tested positive
8
pylori
8
patients carrying
8
cystic fibrosis
8
pylori antigen
8
stool specimens
8
clostridium difficile
8
controls patients
8
p=001 fourteen
4
466% stool
4
antibiotic severity
4
fourteen 466%
4
mutations p=001
4
carrying severe
4
severe mutations
4
differences antibiotic
4

References

(Supplied by CrossRef)

MJ Welsh et al.
Neuron 1992

H Kopelman et al.
N Engl J Med 1985

JM Littlewood et al.
Br Med Bull 1992

MJ Blaser et al.
J Infect Dis 1990

K Przyklenk et al.
Serodiagn Immunother Infect Dis 1989

G Perez-Perez et al.
Infect Immun 1986

S Koletzko et al.
Gut 2003

TV Riley et al.
Eur J Clin Microbiol Infect Dis 1998

WL George et al.
J Clin Microbiol 1982

AM Bourgault et al.
Clin Microbiol Infect 1999

E Mylonakis et al.
Arch Intern Med 2001

Similar Publications